Free Trial
NASDAQ:BBLG

Bone Biologics (BBLG) Stock Price, News & Analysis

Bone Biologics logo
$3.02 -0.01 (-0.33%)
Closing price 07/25/2025 04:00 PM Eastern
Extended Trading
$3.02 +0.00 (+0.17%)
As of 07/25/2025 05:02 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

About Bone Biologics Stock (NASDAQ:BBLG)

Key Stats

Today's Range
$2.95
$3.13
50-Day Range
$2.86
$6.20
52-Week Range
$2.84
$22.20
Volume
47,637 shs
Average Volume
1.48 million shs
Market Capitalization
$1.66 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Bone Biologics Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
15th Percentile Overall Score

BBLG MarketRank™: 

Bone Biologics scored higher than 15% of companies evaluated by MarketBeat. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    There is not enough analysis data for Bone Biologics.

  • Earnings Growth

    Earnings for Bone Biologics are expected to grow in the coming year, from ($5.00) to ($1.95) per share.

  • Price to Book Value per Share Ratio

    Bone Biologics has a P/B Ratio of 0.36. P/B Ratios below 1 indicate that a company could be undervalued with respect to its assets and liabilities.

  • Read more about Bone Biologics' valuation and earnings.
  • Percentage of Shares Shorted

    38.93% of the float of Bone Biologics has been sold short.
  • Short Interest Ratio / Days to Cover

    Bone Biologics has a short interest ratio ("days to cover") of 1.1, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in Bone Biologics has recently increased by 1,644.48%, indicating that investor sentiment is decreasing significantly.
  • Dividend Yield

    Bone Biologics does not currently pay a dividend.

  • Dividend Growth

    Bone Biologics does not have a long track record of dividend growth.

  • Percentage of Shares Shorted

    38.93% of the float of Bone Biologics has been sold short.
  • Short Interest Ratio / Days to Cover

    Bone Biologics has a short interest ratio ("days to cover") of 1.1, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in Bone Biologics has recently increased by 1,644.48%, indicating that investor sentiment is decreasing significantly.
  • News Sentiment

    Bone Biologics has a news sentiment score of 1.87. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 1.07 average news sentiment score of Medical companies.
  • News Coverage This Week

    MarketBeat has tracked 1 news article for Bone Biologics this week, compared to 0 articles on an average week.
  • Search Interest

    Only 3 people have searched for BBLG on MarketBeat in the last 30 days. This is a decrease of -25% compared to the previous 30 days.
  • Insider Buying vs. Insider Selling

    In the past three months, Bone Biologics insiders have not sold or bought any company stock.

  • Percentage Held by Insiders

    Only 6.10% of the stock of Bone Biologics is held by insiders.

  • Percentage Held by Institutions

    Only 34.30% of the stock of Bone Biologics is held by institutions.

  • Read more about Bone Biologics' insider trading history.
Receive BBLG Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Bone Biologics and its competitors with MarketBeat's FREE daily newsletter.

BBLG Stock News Headlines

Trump's 2025 Economic Revolution Is Here Are Your Retirement Savings Ready?
Time is short. Trump's reforms may be coming fast—and the financial system roller coaster may be a ride that you don't want to take with your retirement savings.
Bone Biologics Announces 1-for-6 Reverse Stock Split
See More Headlines

BBLG Stock Analysis - Frequently Asked Questions

Bone Biologics' stock was trading at $5.6418 at the beginning of 2025. Since then, BBLG shares have decreased by 46.5% and is now trading at $3.02.

Bone Biologics Corp. (NASDAQ:BBLG) issued its quarterly earnings results on Monday, May, 12th. The company reported ($1.92) EPS for the quarter, topping analysts' consensus estimates of ($2.88) by $0.96.

Bone Biologics shares reverse split on Tuesday, June 10th 2025.The 1-6 reverse split was announced on Friday, June 6th 2025. The number of shares owned by shareholders was adjusted after the market closes on Monday, June 9th 2025. An investor that had 100 shares of stock prior to the reverse split would have 17 shares after the split.

Bone Biologics (BBLG) raised $8 million in an IPO on Wednesday, October 13th 2021. The company issued 1,510,455 shares at $5.25 per share.

Shares of BBLG stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that Bone Biologics investors own include Broadcom (AVGO), NVIDIA (NVDA), Annovis Bio (ANVS), CrowdStrike (CRWD), Dell Technologies (DELL), FedEx (FDX) and Meta Platforms (META).

Company Calendar

Last Earnings
5/12/2025
Today
7/26/2025
Next Earnings (Estimated)
8/08/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
MED - BIOMED/GENE
Sub-Industry
Medical Equipment
Current Symbol
NASDAQ:BBLG
Previous Symbol
NASDAQ:BBLG
CIK
1419554
Fax
N/A
Employees
2
Year Founded
N/A

Profitability

EPS (Trailing Twelve Months)
N/A
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$4.11 million
Net Margins
N/A
Pretax Margin
N/A
Return on Equity
-130.21%
Return on Assets
-119.39%

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
12.60
Quick Ratio
12.60

Sales & Book Value

Annual Sales
N/A
Price / Sales
N/A
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
$8.39 per share
Price / Book
0.36

Miscellaneous

Outstanding Shares
550,000
Free Float
512,000
Market Cap
$1.66 million
Optionable
Not Optionable
Beta
0.69
A Guide To High-Short-Interest Stocks Cover

MarketBeat's analysts have just released their top five short plays for August 2025. Learn which stocks have the most short interest and how to trade them. Enter your email address to see which companies made the list.

Get This Free Report

This page (NASDAQ:BBLG) was last updated on 7/26/2025 by MarketBeat.com Staff
From Our Partners